250 related articles for article (PubMed ID: 31369199)
21. Progressive Multifocal Leukoencephalopathy Following Combined Rituximab-Based Immune-Chemotherapy for Post-transplant Lymphoproliferative Disorder in a Renal Transplant Recipient: A Case Report.
Windpessl M; Burgstaller S; Kronbichler A; Pieringer H; Kalev O; Karrer A; Wallner M; Thaler J
Transplant Proc; 2018 Apr; 50(3):881-883. PubMed ID: 29661457
[TBL] [Abstract][Full Text] [Related]
22. [Fatal neurological side effect of anti-CD20 antibody treatment].
Schmidt K; Skusa R; Großmann A
Inn Med (Heidelb); 2023 Feb; 64(2):193-196. PubMed ID: 36422661
[TBL] [Abstract][Full Text] [Related]
23. Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.
Felli V; Di Sibio A; Anselmi M; Gennarelli A; Sucapane P; Splendiani A; Catalucci A; Marini C; Gallucci M
Neuroradiol J; 2014 Dec; 27(6):657-64. PubMed ID: 25489887
[TBL] [Abstract][Full Text] [Related]
24. Progressive multifocal leukoencephalopathy--a case report and review of the literature.
Smolle E; Trojan A; Schuster SJ; Haybaeck J
In Vivo; 2014; 28(5):941-8. PubMed ID: 25189911
[TBL] [Abstract][Full Text] [Related]
25. Progressive multifocal leukoencephalopathy in the context of newer therapies in hematology and review of new treatment strategies.
Diamantopoulos PT; Kalopisis K; Tsatsou A; Efthymiou A; Giannakopoulou N; Hatzidavid S; Viniou NA
Eur J Haematol; 2022 May; 108(5):359-368. PubMed ID: 35100451
[TBL] [Abstract][Full Text] [Related]
26. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.
Tan CS; Koralnik IJ
Lancet Neurol; 2010 Apr; 9(4):425-37. PubMed ID: 20298966
[TBL] [Abstract][Full Text] [Related]
27. Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia.
Pejsa V; Lucijanic M; Jonjic Z; Prka Z; Vukorepa G
Ann Hematol; 2019 Jun; 98(6):1509-1510. PubMed ID: 30421169
[No Abstract] [Full Text] [Related]
28. Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: case report and review of the literature.
Freim Wahl SG; Folvik MR; Torp SH
Clin Neuropathol; 2007; 26(2):68-73. PubMed ID: 17416105
[TBL] [Abstract][Full Text] [Related]
29. Management of infections by the human polyomavirus JC: past, present and future.
Hou J; Major E
Expert Rev Anti Infect Ther; 2005 Aug; 3(4):629-40. PubMed ID: 16107201
[TBL] [Abstract][Full Text] [Related]
30. JC Polyomavirus Infection Potentiated by Biologics.
Multani A; Ho DY
Infect Dis Clin North Am; 2020 Jun; 34(2):359-388. PubMed ID: 32444013
[TBL] [Abstract][Full Text] [Related]
31. Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics.
Verheyen J; Maizus K; Feist E; Tolman Z; Knops E; Saech J; Spengler L; Waterboer T; Burmester GR; Pawlita M; Pfister H; Rubbert-Roth A
Med Microbiol Immunol; 2015 Oct; 204(5):613-8. PubMed ID: 25678083
[TBL] [Abstract][Full Text] [Related]
32. Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy.
Seth P; Diaz F; Major EO
J Neurovirol; 2003 Apr; 9(2):236-46. PubMed ID: 12707854
[TBL] [Abstract][Full Text] [Related]
33. Progressive multifocal leukoencephalopathy (PML) in a patient with lymphoma treated with rituximab: A case report and literature review.
Al-Tawfiq JA; Banda RW; Daabil RA; Dawamneh MF
J Infect Public Health; 2015; 8(5):493-7. PubMed ID: 25666327
[TBL] [Abstract][Full Text] [Related]
34. An Evidence-based Review of Anti-CD20 Antibody-containing Regimens for the Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, or Follicular Lymphoma.
Falchi L; Ferrajoli A; Jacobs I; Nava-Parada P
Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):508-518.e14. PubMed ID: 29934061
[TBL] [Abstract][Full Text] [Related]
35. Multifocal progressive leukoencephalopathy occurring after refractory anemia and multiple infectious disorders consecutive to severe lymphopenia.
Hequet O; Salles G; Espinousse D; Dumontet C; Bouafia F; Thieblemont C; Revesz D; Coiffier B
Ann Hematol; 2002 Jun; 81(6):340-2. PubMed ID: 12107566
[TBL] [Abstract][Full Text] [Related]
36. Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy.
Tuccori M; Focosi D; Blandizzi C; Pelosini M; Montagnani S; Maggi F; Pistello M; Antonioli L; Fornai M; Pepe P; Rossi G; Petrini M
Oncologist; 2010; 15(11):1214-9. PubMed ID: 21041380
[TBL] [Abstract][Full Text] [Related]
37. Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981-1989.
Gillespie SM; Chang Y; Lemp G; Arthur R; Buchbinder S; Steimle A; Baumgartner J; Rando T; Neal D; Rutherford G
Ann Neurol; 1991 Oct; 30(4):597-604. PubMed ID: 1665053
[TBL] [Abstract][Full Text] [Related]
38. Obinutuzumab use complicated by progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukemia: a case report.
Turine G; London F
Acta Neurol Belg; 2021 Jun; 121(3):781-783. PubMed ID: 33063195
[No Abstract] [Full Text] [Related]
39. Rituximab-Associated Progressive Multifocal Leukoencephalopathy: A Twenty-Year Update.
Bennett CL; Witherspoon B; Carson KR
Cancer Treat Res; 2022; 184():103-111. PubMed ID: 36449191
[TBL] [Abstract][Full Text] [Related]
40. The pathogenesis of progressive multifocal leukoencephalopathy.
Berger JR; Khalili K
Discov Med; 2011 Dec; 12(67):495-503. PubMed ID: 22204766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]